WAVE Life Sciences (NASDAQ: WVE) reported Q4 EPS of ($0.61), $0.10 worse than the analyst estimate of ($0.51). Revenue for the quarter came in at $1.77 million versus the consensus estimate of $15.79 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.